Xeplokind Syrup is a multi-ingredient pharmaceutical formulation designed to provide effective relief from respiratory conditions characterized by productive cough and bronchial congestion. Each 5 ml of the syrup contains Ambroxol 15 mg, a mucolytic agent that facilitates the breakdown and clearance of mucus from the respiratory tract, thereby improving airway patency. Guaifenesin 50 mg acts as an expectorant, promoting the expulsion of phlegm and reducing chest congestion. Menthol 2.5 mg provides a soothing effect on the throat and nasal passages, offering symptomatic relief through its mild anesthetic and cooling properties. Terbutaline 1.25 mg, a selective beta-2 adrenergic receptor agonist, serves as a bronchodilator that relaxes bronchial smooth muscle, alleviating bronchospasm and improving airflow. Xeplokind Syrup is indicated for the management of acute and chronic bronchitis, asthma exacerbations, and other respiratory ailments involving mucus hypersecretion and bronchoconstriction. It should be used under medical supervision, particularly in patients with cardiovascular disorders, hypertension, or hypersensitivity to any component. The combination of mucolytic, expectorant, bronchodilator, and soothing agents in Xeplokind Syrup provides comprehensive symptomatic relief, enhancing patient comfort and respiratory function.